Characterization of orofacial features in sclerodermatous chronic graft‐versus‐host disease
- 21 March 2024
- journal article
- research article
- Published by Wiley in Oral Diseases
- Vol. 30 (8) , 5082-5090
Abstract
Background: Chronic graft‐versus‐host disease (cGVHD) is a leading cause of morbidity and mortality following allogeneic hematopoietic cell transplantation (alloHCT). The sclerodermatous form of cGVHD can be particularly debilitating; however, orofacial sclerodermatous involvement remains poorly described.Objective: To characterize orofacial features of sclerodermatous cGVHD in a single center cohort of patients who underwent alloHCT.Study Design: Retrospective data were collected from electronic medical records and analyzed descriptively.Results: There were 39 patients who received alloHCT between 1993 and 2017 and developed orofacial sclerodermatous cGVHD. Concomitant cutaneous sclerodermatous cGVHD was common (n = 20, 51%). Orofacial sclerodermatous cGVHD features included fibrous bands of the buccal mucosa (n = 23, 59%), limited mouth opening (n = 19, 54%), perioral fibrosis (n = 8, 21%), and focal gingival recession (n = 4, 10%). Oral mucosal fibrosis was observed at the site of active or resolved chronic lichenoid inflammation in 30 patients, with all but two also presenting with a history of ulcerations. Management included jaw stretching exercises (n = 10; 6 stable/improved), surgery (n = 3; 2 improved), and intralesional corticosteroid injections (n = 2; 2 improved).Conclusions: Orofacial involvement with sclerodermatous cGVHD can present with multiple manifestations including fibrous banding, limited mouth opening, perioral fibrosis, and focal gingival recession. Surgical and non‐surgical management strategies may improve clinical function and reduce morbidity.Keywords
This publication has 31 references indexed in Scilit:
- Photobiomodulation therapy in the management of chronic oral graft-versus-host diseaseSupportive Care in Cancer, 2016
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group ReportTransplantation and Cellular Therapy, 2015
- Pulmonary Symptoms Measured by the National Institutes of Health Lung Score Predict Overall Survival, Nonrelapse Mortality, and Patient-Reported Outcomes In Chronic Graft-Versus-Host DiseaseTransplantation and Cellular Therapy, 2014
- Recommendations for the care of oral involvement in patients with systemic sclerosisArthritis Care & Research, 2011
- Oral Graft-Versus-Host DiseaseDental Clinics of North America, 2008
- Clinical Evaluation of Oral Chronic Graft-Versus-Host DiseaseTransplantation and Cellular Therapy, 2008
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group ReportTransplantation and Cellular Therapy, 2005
- Oral Chronic Graft-versus-Host Disease in Pediatric Patients after Hematopoietic Stem Cell TransplantationTransplantation and Cellular Therapy, 2005
- Effects of a nonsurgical exercise program on the decreased mouth opening in patients with systemic sclerodermaClinical Oral Investigations, 2003
- The nonsurgical treatment of microstomia in scleroderma: A pilot studyOral Surgery, Oral Medicine, Oral Pathology, 1984